ADT vs SRPT · P/E 13, rev $2.59B vs rev $1.13B
ADT Inc (ADT) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
ADT Inc (ADT) is a security & protection services company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported ADT revenue for 2026-06-30 was $2.59B. Net income was $322.2M. ADT currently screens at market cap $7.09B and trailing P/E 13.0.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
ADT currently screens at market cap $7.09B and trailing P/E 13.0. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ADT and SRPT stock pages for the full models.
Not investment advice.